Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

https://www.soho2019.com/

 

Mantle Cell Lymphoma
12:35

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

2019 Frontline Therapy for Mantle Cell Lymphoma: Cytarabine as a Key Drug and Only Maintenance Rituximab is Beneficial in Younger Patients, CHOP / Bendamustine for Older Patients

FEATURING Simon Rule
  • 32 views
  • October 18, 2019
15:27

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Novel Salvage Therapy in Mantle Cell Lymphoma: Discussion on Agents Other than BTKi and Venetoclax, Ibrutinib Combinations

FEATURING Simon Rule
  • 323 views
  • October 18, 2019
  • 4
15:47

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Who Is a Candidate for Watch and Wait Therapy in MCL / What Are the Clinical and Biologic Features of Successfully Monitored MCL Patients?

FEATURING Anita Kumar
  • 22 views
  • October 18, 2019
11:48

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Safety and Efficacy of Acalabrutinib + Bendamustine / Rituximab in Patients with Treatment-Naive or R/R MCL

FEATURING Michael Wang
  • 213 views
  • October 18, 2019
  • 1